GGrantIndex
← Search

Protocol Review and Monitoring System

$239,009P30FY2018CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications, trials & patents

Trial NCT07639528Trial NCT07594626Trial NCT07594548Trial NCT07290543Trial NCT07261657Trial NCT07178301Trial NCT07169617Trial NCT07050186Trial NCT07042919Trial NCT06959641Trial NCT06813898Trial NCT06723457Trial NCT06630416Trial NCT06571734Trial NCT06499870Trial NCT06410248Trial NCT06327477Trial NCT06247540Trial NCT06244004Trial NCT06242834Trial NCT06184750Trial NCT06164275Trial NCT06137651Trial NCT06062498Trial NCT06060587Trial NCT06022822Trial NCT05879250Trial NCT05852041Trial NCT05802186Trial NCT05744739Trial NCT05733000Trial NCT05620771Trial NCT05576896Trial NCT05545150Trial NCT05453799Trial NCT05419011Trial NCT05411107Trial NCT05236036Trial NCT05202782Trial NCT05093387Trial NCT04931017Trial NCT04910425Trial NCT04795869Trial NCT04767984Trial NCT04753216Trial NCT04576104Trial NCT04550481Trial NCT04250051Trial NCT04227028Trial NCT04200443Trial NCT04049227Trial NCT04047706Trial NCT04033432Trial NCT04009044Trial NCT03854474Trial NCT03812562Trial NCT03742258Trial NCT03723915Trial NCT03704714Trial NCT03513484Trial NCT03317405Trial NCT03278925Trial NCT03226249Trial NCT03213041Trial NCT03146650Trial NCT03077828Trial NCT03070002Trial NCT03061188Trial NCT03048500Trial NCT03044730Trial NCT03036930Trial NCT03020017Trial NCT02993159Trial NCT02968810Trial NCT02965703Trial NCT02901899Trial NCT02892734Trial NCT02871323Trial NCT02861040Trial NCT02847559Trial NCT02837029Trial NCT02819804Trial NCT02808143Trial NCT02805868Trial NCT02794883Trial NCT02774681Trial NCT02743364Trial NCT02720484Trial NCT02694809Trial NCT02536794Trial NCT02530619Trial NCT02530502Trial NCT02530125Trial NCT02481310Trial NCT02365480Trial NCT02357810Trial NCT02314156Trial NCT02242097Trial NCT02237183Trial NCT02232516

Abstract

ABSTRACT ? PROTOCOL REVIEW AND MONITORING SYSTEM The Protocol Review and Monitoring System (PRMS) of the Robert H. Lurie Comprehensive Cancer Center (LCC) falls under the purview of the Scientific Review Committee (SRC), one of several committees that comprise LCC's research oversight program. The LCC's PRMS has received continuous NCI approval since 1998. The SRC is a multidisciplinary committee that consists of a core group of members providing the necessary expertise in the principal disciplines of clinical oncology research, with expertise of representatives from LCC's Quantitative Data Sciences Core (which includes biostatistics), Translational Research, Behavioral and Health Sciences, and Pharmacy groups. The SRC is chaired by A. B. Benson III, MD, and co-chaired by A. Rademaker, PhD, and J. Sosman, MD (new in this grant period). The focus of the SRC is the review of cancer relevant clinical trials for scientific merit, prioritization, and monitoring scientific progress. The SRC has the authority to approve protocols that meet the scientific merit and scientific priorities of the center and to terminate protocols that do not demonstrate sufficient scientific progress. Improvements made over this grant cycle include an enhanced role for Disease Teams in protocol prioritization and monitoring, improved communication among the research oversight committees and with the Clinical Trials Office, as well as broadened representation of SRC membership.

View original record on NIH RePORTER →